Synbufo (budesonide/formotenol) / Intech Biopharm - LARVOL DELTA

Yide compound asthma drug SYN010 listed in Taiwan [Google translation] (China Times) - "Yide (6461)'s compound inhaler SYN010 was launched in Taiwan in April. At present, listing applications have been submitted in Hong Kong and Macau. Listing applications in Southeast Asian countries and evidence collection in mainland China are also being submitted in succession this year (2023). For the US market, applications will be made through the P4 route."

Launch non-US • Asthma • Respiratory Diseases

A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal Block (clinicaltrials.gov) - P1; N=99; Completed; Sponsor: Intech Biopharm Ltd.

Clinical • New P1 trial • Asthma • Chronic Obstructive Pulmonary Disease • Respiratory Diseases